Finding effective solutions to the world’s health issues requires novel, holistic approaches and collaborative ingenuity. Healthcare companies must therefore increasingly shift their focus to the research and development of medical technologies, biopharmaceuticals, and innovative therapies to treat conditions and diseases that are difficult or nearly impossible to tackle using traditional medicines. Such a reality is…

Continuing the dialogue surrounding precision medicines and patient-centered care from a similar event three years earlier, the U.S.-Taiwan Innovative Patient-Centered Care Symposium, co-hosted by AmCham Taipei and the American Institute in Taiwan (AIT), took place at the AIT compound in Neihu on December 18. The aim of the event was to demonstrate the value of…

Over a period of more than 40 years, Taiwan has built up a strong environment for immunization, drastically decreasing once-prevalent diseases and generating widespread trust in Taiwan’s public health system. However, while Taiwanese citizens currently enjoy almost universal access to a wide range of publicly funded vaccines, insufficiencies in that funding threatens to reduce the…

Most of AmCham Taipei’s member companies in the medical device field are sales and marketing arms of the world’s major multinational, especially American, brands. The profiles below introduce two member companies that are exceptions in that their forte is manufacturing, with Taiwan as their main base. As private companies they don’t disclose their financial information,…

Several of the candidates for the Democratic nomination for U.S. president are advocating a government-run plan to provide health-insurance coverage to all Americans, sometimes referred to “Medicare for All.” As a single-payer healthcare system, this type of plan is similar to Taiwan’s National Health Insurance (NHI). Could the Taiwan experience serve as a practical reference…